ReWalk Robotics

ReWalk Robotics, a developer of exoskeletons for people with lower-limb disabilities, is seeking to sell nearly 5.6 million ordinary shares, plus more, worth about $6.2 million. Marlborough, Mass.-based ReWalk is also offering more than 4.5 million ordinary shares which are issuable upon the exercise of outstanding warrants, according to a news release. ReWalk is also…

The COVID-19 pandemic has brought attention to the need for innovative systems for stroke rehabilitation, said ReWalk Robotics, which donated a ReStore exo-suit to Brooks Rehabilitation.

In July 2020, autonomous vehicles, industrial automation, and surgical robots continued to receive funding at steady levels in comparison with the same period last year.

ReWalk Robotics and the Wyss Institute are exploring how telehealth capabilities, including remote data provision, analysis and therapy, can improve exoskeletons.

Reported robotics investments in June 2019 focused on transportation, AI and software, manufacturing, and healthcare.

ReWalk Robotics has won CE Mark clearance in the European Union for its ReStore soft exo-suit designed for use in stroke rehabilitation. The Marlborough, Mass.-based company touted the clearance as the first for a soft exo-suit in the region. The ReStore exo-suit features a soft, garment-like design and is intended to adaptively synchronize with a…

Robotics investments totaled at least $4.3 billion in February 2019 in a steep increase from January, which had about $1.4 billion. In addition, companies reported approximately $3.9 billion worth of acquisitions this past month. Any political or economic jitters have not yet harmed the mood for robot deals. The Robotic Industries Association noted yesterday that robot…

Many of the most visible demonstrations of exoskeletons have been for assisting people with disabilities. However, limitations of weight, power, and cost have resulted in slow rates of adoption. In the meantime, the technology continues to advance, with industrial exoskeletons providing application experience. While the majority of today’s $130 million wearable robotics market is for…

The U.S. Department of Veterans Affairs (VA) in June 2018 revised its national policy for ReWalk Robotics‘ powered exoskeleton for qualifying veterans with spinal cord injuries (SCI). The revision expands access to training program locations among the VA network and private rehabilitation centers throughout the VA’s Veterans Choice Program. The updated policy also includes further…

Clinical trials for the ReWalk Robotics ReStore soft exoskeleton are expanding to five research centers in the United States. The centers involved in the ReWalk Robotics ReStore trials include the Shirley Ryan AbilityLab (Chicago), Spaulding Rehabilitation Hospital (Boston), the MossRehab Stroke and Neurological Disease Center (Elkins Park, PA), TIRR Memorial Hermann (Houston), and the Kessler Foundation (East…

ReWalk Robotics, which develops rigid and soft exoskeletons to help people walk again after injuries and strokes, is expanding into China expand thanks to a $20 million investment from Hong Kong-based Timwell Corporation Limited. ReWalk and Timwell affiliate companies will form a joint venture in China to develop, manufacture and market ReWalk’s exoskeletons in China,…

ReWalk Robotics today saw shares dip slightly after releasing preliminary financial results for its 3rd quarter despite posting revenues ahead of consensus on Wall Street. The Israel-based company said it expects to post sales of $1.7 million for the 3 months ended Sept. 30, up 21.4% from the $1.4 million the company posted for the…

ReWalk Robotics said today it completed all internal processes related to its Restore robotic rehabilitation softsuit exoskeleton and is ready to initiate clinical trials of the device in 2018, with hopes for a commercial launch in the same year. The Restore softsuit is designed to transmit power to key joints in the legs with cable…